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Treatment of Radiation Injuries
Edited by D. Browne, J.F. Weiss, T.J. MacVittie and M.V.
Pillai, New York: Plenum, 1990, 249 pp. $75.00.
This reviewer has a bias against conference proceedings,
particularly those published over 18 months after the actual
conference they report, but this turned out to be a very
useful volume which one can highly recommend. American
conference organisers have a penchant for 'consensus'. This
meeting in May 1989 brought together some 95 participants
- many from the US military and nuclear establishment; but
with contributions from the UK, Canada, Brazil, Germany,
Italy, Japan, the Netherlands and Spain. The discussion was
organised in three major sections: Haemopoietic Injury Com-
plications, Infectious Complications, and Combined Injury
Complications each of which concludes with a consensus
panel. The final section is devoted to recording and exploring
this consensus. It begins with two useful review papers: A
historical perspective on the therapy of total body radiation
injury, by the much respected Eugene Cronkite of Brook-
haven National Laboratories, the other a 'warts and all'
presentation, on the acute effects of radiation exposure fol-
lowing the Chernobyl accident by Professor Angelina Gus-
kova and her colleagues. A further review paper explores the
most exciting of the new prospects for treatment of radiation
injury by human colony-stimulating factors, by Dr William
Peters of Duke University.
Most doctors, even radiologists who are daily users of
ionising radiation, and occupational and public health doc-
tors are by and large badly informed on radiation casualty
management. A general acquaintance with the problems -
and the true magnitude of the hazards - which allows doc-
tors to be well enough informed to reassure those who are
not at significant risk, is available from slim and easy to read
volumes such as the National Radiological Protection Board's
'Living with Radiation'. Treatment of Radiation Injuries
fulfils a different function; it is a worthwhile 'state of the art'
review, albeit at May 1989, well-presented and sufficiently
comprehensive to be of real value. Not least, it has inside the
back cover (as well as in the text) a simplified 'flow chart'
which could be of use to any physician confronted with the
problem of management of radiation casualties. It is unemo-
tional, it is practical, it contains some very sound science
sanely presented, and I can certainly recommend it to
occupational and public health physicians as a sufficiently
inexpensive part of their personal library.
R.J. Berry
Chemotherapy of Gynecologic Cancer
2nd Edition, 1990. Gunter Deppe. New York: Wiley-Liss.
518 pp. $165.00
This book aims to provide up-to-date guidance about
adjuvant, curative and palliative chemotherapy treatment of
all malignancies of the female reproductive tract, and breast
cancer as well. The first quarter of the book details basic
principles of cancer chemotherapy, adverse effects of treat-
ment and interpretation of clinical trials. Chemotherapeutic
management of the various gynaecologic tumours is reviewed
in turn, and the final quarter of the book comprises a pot
pourri of 'special interest' chapters including immunotherapy,
monoclonal antibody therapy and intraperitoneal therapy.
Unfortunately the merit of this book is severely compro-
mised by the artificial separation of chemotherapy from the
other modalities of treatment of gynaecologic malignancy,
and by the often superficial manner in which this difficult
subject is addressed.
Firstly, gynaecologic oncology is a specialty which is
critically dependant upon the integrated use of surgery
radiotherapy and chemotherapy. To present a 'comprehen-
sive' study of one of these modalities in isolation is a contra-
diction in terms.
Secondly, the manner in which chemotherapy treatment is
reviewed in this book is unhelpful. It is a fact that with very
rare exceptions, ideal chemotherapy does not exist, and thus
firm guidelines cannot be generally issued. Nevertheless,
simply to summarise briefly selected reports ofchemotherapy
trials and provide little or no interpretation or criticism is to
err too far in the opposite direction. For example, the treat-
ment strategy for epithelial ovarian cancer is summed up as
follows: 'Stage III and IV disease patients require optimal
debulking followed by chemotherapy, cisplatin-based com-
bination chemotherapy is currently used'.
Although it is a useful source for a large number of
pre-1988 references relating to the chemotherapy of
gynaecologic cancer, this book has little else to recommend
it.
R. Osborne
The Cytotoxics Handbook
Edited by M. Allwood and P. Wright, Oxford: Radcliffe
Medical Press, 1990, 239 pp. £29.50.
This extremely useful and clearly written book has been
produced by The Cytotoxic Services Working Group, which
is made up of 27 pharmacists, pharmacy technicians and
representatives of the pharmaceutical industry. The stated
aims of the group were to produce a manual on how to set
up and operate pharmacy-based cytotoxic services with
specific detail on equipment, facilities, Health and Safety,
documentation and training: and a compendium of cytotoxic
drugs detailing their pharmaceutical properties, reconstitution
details and stability in secondary packaging systems based
upon an informed review of the literature. The book is
primarily written for pharmacists involved in establishing or
updating centralised cytotoxic services.
The first section of the book deals with cytotoxic services.
It starts by considering the sort of information that should
be collected and considered before beginning to set up a
cytotoxic reconstitution service and goes on to detail the type
and level of service that it is possible to provide. These
services range from pharmacy-controlled centralised units
through pharmacy-controlled satellite units, to nurse/doctor
operated, ward/clinic based, controlled or uncontrolled envir-
onments. Commercial services, either industrial or NHS bas-
ed are also briefly considered. For each of these options
potential advantages and disadvantages are presented. The
next section deals with facilities, including equipment selec-
tion and types of working environment. The various types of
laminar flow cabinets and isolators are considered. It should
be emphasised that this book does not provide a blueprint as
to how an ideal reconstitution service should be set up and
neither should it be expected to have done so. It does how-
ever provide a useful starting point by detailing the various
factors which must be considered prior to embarking upon
the establishing of a successful service, the level of which will
be very variable from centre to centre depending upon a
multitude of individual factors. The next part of the book
considers protective clothing and disposables. There follows a
useful chapter on ambulatory infusion pumps which is for
some reason separated by 40 pages from a chapter on Home
Based Cytotoxic Chemotherapy. In between are chapters on
Health and Safety Aspects of Cytotoxic Services; documenta-
tion including consideration of methods of prescribing and
ordering drugs, clinical protocols, drug monographs, work-
sheets, labelling, information documents for ward/clinic staff
and pharmacy patient records. The next chapter considers612 BOOK REVIEWS
the education and training of the staff who will be involved
in cytotoxic reconstitution which is followed by an invaluable
chapter on the management of extrasavation of cytotoxic
drugs.
Section two of the book is likely to be a constant source of
reference. It comprises a valuable alphabetical listing of
monograhs of individual drugs that are used intravenously.
Each monograph has been prepared by a named member of
the working group according to a common structure. There
is a section on nomenclature which includes the names of
manufacturers and suppliers in the UK. There follows sec-
tions on chemistry, stability profile, clinical usage, details of
how individual drugs are prepared for injection or infusion
together with handling precautions. The final section con-
siders how residual drug and contaminated articles should be
destroyed. It should be emphasised that the working group
has deliberately refrained from providing details of 'standard
protocols for various indications'.
In summary this is a book that should be read by any
members of the 'Oncology Team' involved in setting up a
reconstitution service. It should also be available in the
departmental library of all Oncology Departments and all
Pharmacies where any cytotoxic drugs are reconstituted and
administered.
T.J. Perren
Evolution of Cancer
S. Okuyama and H. Mishina, Tokyo: University of Tokyo
Press, 1990, 266pp. £57.50.
This is a highly provocative book, written by two clinical
radiotherapists, on the evolution ofcancer. The authors base
their approach to the treatment of cancer on the hypothesis
that cancer represents a process of evolution in reverse,
which they call 'devolution'. This concept is applied to
develop theories on carcinogenesis, epidemiology, diagnosis
and especially the strategy of cancer treatment. Fanconi's
anaemia is cited as an evolutionary experiment of nature on
carcinogenesis. The tumours described in patients with the
DNA repair syndrome were classified according to their
epithelial, -non-epithelial and gonadal origin. The early
manifestation of non-malignancies and the later occurrence
of epithelial tumours is considered as a support for the
evolution theory. The cancer incidence in Japan following the
explosion of the atomic bombs would also support this
evolution theory. The parallel evolution of biology with the
physicochemical alterations on earth are also cited in support
of the evolution theory of cancer. Such arguments are then
used for the formulation of a therapeutic strategy, starting
with the repair of DNA damage, via carbohydrate
biochemistry to immunotherapy and antiviral therapy.
A large variety of arguments are used to formulate a
strategy in surgery, radiotherapy, chemotherapy and immuno-
therapy. For most readers of this book it will be difficult to
find practical advice regarding strategy of treatment that will
have to be used. The two last chapters deal with different-
iation of cancer cells induced by the immunostimulant Besta-
tin, sex hormones and prostaglandins.
This book is difficult reading, because the authors use a
wealth of biological data to search for support of their
concepts on evolution and devolution of cancer. They have
not succeeded in formulating a clear strategy for treatment,
based on the postulated mechanisms of evolution.
F.J. Cleton
An Introducton to Radiobiology, A.H.W. Nias, New York:
John Wiley & Sons, 1990, 346pp. £17.50.
The stated aim of this book is 'to provide an extremely
readable introduction to the subject of radiobiology'. How-
ever, it is perhaps better described as an introductory text-
book of cellular radiobiology designed for would-be radio-
biologists and medical physicists to peruse prior to consulting
more advanced sources. It is not a primer to be read by the
uninitiated where the reader is gently led to deeper levels of
understanding. Despite this caveat the book has many
admirable qualities in its 346 pages including copious
graphics and illustrative diagrams and succinct summaries of
the basic conclusions at the end of each of its 20 chapters.
Chapter 1 is a rather eclectic ten pages of the history of
radiobiology with paragraphs on radiation, radiation units
and timescales. Chapter 2, although entitled 'Cells and Tis-
sues' is really devoted to a single aspect of cell biology viz.
cell synchronisation and methods to attain it. Unfortunately,
the first sentence of this chapter implies that all human cells
are nucleate and this is only amended later in the text. The
author also repeats the ancient phrases about G1 and G2
being 'gaps in our knowledge' of cell cycle events. This is
hardly tenable after nearly 40 years of research into pre- and
post-DNA phase biochemistry and cell metabolism. Chapter
3 goes into the greater details of cell population kinetics.
Chapter 4 is the standard introductory account of radia-
tion physics to be found in numerous kindred textbooks. It is
high time these were all updated to include the last decades
exciting advances in microdosimetry so as to illustrate the
meaning of 'dose' at the cellular, subcellular and molecular
levels.
Chapter 5 'Subcellular Radiobiology' is only 14 pages and
purports to cover 'radiation biochemistry', 'molecular
radiobiology' and 'cytogenetics' - a very tall order. A critical
opportunity has however been missed, namely the provision
of a clear popular exposition of DNA damage and its repair
and misrepair. This topic, so central to the chain of events
between energy absorption and final expression of biological
damage, is barely mentioned. This contrasts with repair at
the cellular and tissue levels which are fully discussed in
Chapter 7.
Chapter 6 describes the post irradiation fate of individual
cells - giant cell formation, interphase death and then
focusses most of its attention, quite correctly, on mitotic
death.
Chapter 8 on 'Intrinsic Radiosensitivity' discusses the
various shapes of cell survival curves using both in vitro and
in vivo studies. It touches on the 'SF at 2 Gy' a current hot
topic in radiobiology but much of the chapter hinges on the
older and all but discredited target theories, rather than more
recent interpretations of repair/saturation models. Two small
errors have also crept into the algebra of this chapter. The
next section is on the special qualities of densely ionising
radiations such as alpha particles, neutrons and pi-mesons.
Chapter 10, on the radiosensitising and dose modifying
effects of oxygen is good but marred by one of the figures
(Figure 10:7) which indicates a crossing over of two survival
curves clearly implying oxygen protects cells at doses below
2 Gy. This contradicts the text and will puzzle all casual
readers. The next chapter is on sulphydryl(-SH) containing
radioprotective agents and on electron affinic radiosensitisers
and is illustrated by data on clonogenic assays.
Chapter 12 compares the radiobiology of normal and
malignant cells with the emphasis yet again on clonogenic
assays. The book is beginning to feel repetitive. There follow
two chapters of pathology, the first on tissue effects and the
second on the whole body radiation syndromes.
Chapters 15 and 16 are a potted version of the
radiobiological basis of fractionation radiotherapy.
The author describes the final 60 pages as covering the
effects of low dose and low dose rate radiation; the study of